Pharmaceuticals

Global Adult Vaccines Market Projected to Expand at 9% CAGR by 2029

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Adult Vaccines Market Size Likely To Evolve From 2025 Through 2034?

The adult vaccines market has experienced strong growth in recent years. It is projected to increase from $22.82 billion in 2024 to $24.21 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.1%. This historical expansion can be attributed to an increasing aging population, government vaccination programs, rising awareness of preventive healthcare, continuous vaccine development and innovation, and various public health campaigns.

The adult vaccines market size is anticipated to expand significantly in the coming years, reaching $34.19 billion by 2029, with a compound annual growth rate (CAGR) of 9.0%. This projected growth during the forecast period is due to factors such as the appearance of new infectious threats, a growing emphasis on immunization registries, the increasing danger of antimicrobial resistance, global endeavors for pandemic preparedness, a shift towards customized vaccines, and a greater focus on maternal immunization. Prominent trends expected in this period include the integration of digital health, continuous technological advancements in vaccine manufacturing, partnerships between governments and pharmaceutical companies, improvements in vaccine delivery methods, and the expansion of existing immunization programs.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

What Are The Main Drivers Boosting The Adult Vaccines Industry’s Expansion?

The growing incidence of contagious diseases is propelling the adult vaccine market. These are illnesses that transmit between individuals. Vaccines enable people to develop immunity against infectious diseases, making them a highly effective method for combating infections. For example, in March 2023, the Centers for Disease Control and Prevention, a US-based national public health agency, reported 8,300 tuberculosis cases in the United States in 2022, a rise from 7,874 in 2021. TB incidence during 2022 climbed slightly to 2.5 per 100,000 persons, compared with 2.4 during 2021. Thus, the increasing spread of contagious diseases is stimulating the expansion of the adult vaccine market.

What Are The Leading Segments Analyzed In The Adult Vaccines Market?

The adult vaccines market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines

3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis

4) By End Users: Healthcare Firms, Hospitals

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines

Which Market Trends Are Creating New Opportunities In The Adult Vaccines Industry?

Product innovations are a prominent and increasing trend within the adult vaccines market. Major companies in this sector are rolling out new products to uphold their presence. For example, in August 2022, GSK, a UK-based biopharma firm, and IQVIA, an India-based global provider of advanced analytics, technology solutions, and clinical research services, unveiled Vaccine Track. This data trend platform is designed to assist in enhancing adult vaccination rates across communities nationwide. The resource will supply regular and relevant data on emerging trends to guide and bolster public health endeavors.

Which Key Market Players Are Investing In Expansion And Innovation Of Adult Vaccines Market?

Major companies operating in the adult vaccines market include GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

How Is Adult Vaccines Market Demand Varying Across Different Regions?

North America was the largest region in the adult vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Adult Vaccines Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9038&type=smp

Browse Through More Reports Similar to the Global Adult Vaccines Market 2025, By The Business Research Company

Iot In Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/iot-in-manufacturing-global-market-report

Power Generators Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/power-generators-global-market-report

Ventricular Assist Device Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795